Literature DB >> 16314870

Serine racemase binds to PICK1: potential relevance to schizophrenia.

K Fujii1, K Maeda, T Hikida, A K Mustafa, R Balkissoon, J Xia, T Yamada, Y Ozeki, R Kawahara, M Okawa, R L Huganir, H Ujike, S H Snyder, A Sawa.   

Abstract

Accumulating evidence from both genetic and clinico-pharmacological studies suggests that D-serine, an endogenous coagonist to the NMDA subtype glutamate receptor, may be implicated in schizophrenia (SZ). Although an association of genes for D-serine degradation, such as D-amino acid oxidase and G72, has been reported, a role for D-serine in SZ has been unclear. In this study, we identify and characterize protein interacting with C-kinase (PICK1) as a protein interactor of the D-serine synthesizing enzyme, serine racemase (SR). The binding of endogenous PICK1 and SR requires the PDZ domain of PICK1. The gene coding for PICK1 is located at chromosome 22q13, a region frequently linked to SZ. In a case-control association study using well-characterized Japanese subjects, we observe an association of the PICK1 gene with SZ, which is more prominent in disorganized SZ. Our findings implicating PICK1 as a susceptibility gene for SZ are consistent with a role for D-serine in the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16314870     DOI: 10.1038/sj.mp.4001776

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  44 in total

1.  Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Authors:  Surendra P Singh; Vidhi Singh
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

2.  Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.

Authors:  Ariel A Jacobi; Sarah Halawani; David R Lynch; Hong Lin
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

3.  Structure of PICK1 and other PDZ domains obtained with the help of self-binding C-terminal extensions.

Authors:  Jonathan M Elkins; Evangelos Papagrigoriou; Georgina Berridge; Xiaowen Yang; Claire Phillips; Carina Gileadi; Pavel Savitsky; Declan A Doyle
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

Review 4.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

Review 5.  Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Authors:  Joseph T Coyle; Alo Basu; Michael Benneyworth; Darrick Balu; Glenn Konopaske
Journal:  Handb Exp Pharmacol       Date:  2012

6.  Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for β-elimination function.

Authors:  David L Nelson; Greg A Applegate; Matthew L Beio; Danielle L Graham; David B Berkowitz
Journal:  J Biol Chem       Date:  2017-07-10       Impact factor: 5.157

7.  FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.

Authors:  Elena Dikopoltsev; Veronika N Foltyn; Martin Zehl; Ole N Jensen; Hisashi Mori; Inna Radzishevsky; Herman Wolosker
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 8.  Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds.

Authors:  Sandra Chánez-Paredes; Armando Montoya-García; Michael Schnoor
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

Review 9.  NMDA receptor regulation by D-serine: new findings and perspectives.

Authors:  Herman Wolosker
Journal:  Mol Neurobiol       Date:  2007-09-12       Impact factor: 5.590

10.  Serine racemase regulated by binding to stargazin and PSD-95: potential N-methyl-D-aspartate-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (NMDA-AMPA) glutamate neurotransmission cross-talk.

Authors:  Ting Martin Ma; Bindu D Paul; Chenglai Fu; Shaohui Hu; Heng Zhu; Seth Blackshaw; Herman Wolosker; Solomon H Snyder
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.